33 Stocks Moving In Thursday's Mid-Day Session

Gainers

• Eargo, Inc. EAR shares jumped 50.8% to $6.88 after the company announced the Department of Justice confirmed to it that the previously-announced criminal probe is no long active.
• Alterity Therapeutics Limited ATHE climbed 42.9% to $1.1850 after the company announced it was granted a new US patent for "Compounds for and Methods of Treating Diseases."
• Vocera Communications, Inc. VCRA gained 26.5% to $79.09 after Stryker announced a definitive agreement to acquire the company.
• Kaival Brands Innovations Group, Inc. KAVL rose 22.5% to $0.77 after declining more than 11% on Wednesday.
• Magenta Therapeutics, Inc. MGTA shares gained 14.7% to $5.11. Goldman Sachs upgraded Magenta Therapeutics from Neutral to Buy and raised the price target from $7 to $8.
• Plus Therapeutics, Inc. PSTV shares gained 13% to $1.4588. Plus Therapeutics entered into an agreement with The University of Texas Health Science Center at San Antonio for a worldwide exclusive license to develop and commercialize novel interventional therapeutics for cancer.
• Bed Bath & Beyond Inc. BBBY rose 9.5% to $14.64 after the company reported Q3 earnings results and issued guidance.
• Resources Connection, Inc. RGP gained 8.8% to $19.80 after reporting better-than-expected Q2 results.
• Lamb Weston Holdings, Inc. LW surged 7.3% to $67.73 after the company announced better-than-expected Q2 EPS and sales results.
• SomaLogic, Inc. SLGC rose 6.7% to $11.03 after the company announced an exclusive partnership with Illumina to develop sequencing-based proteomic solutions.

Check out these big penny stock gainers and losers

Losers

• Aligos Therapeutics, Inc. ALGS shares fell 49.7% to $5.34 after the company announced that it has halted further development of its STOPS drug candidate, ALG-010133.
• Berkeley Lights, Inc. BLI dropped 34.9% to $10.60 after the company issued weak sales forecast for FY21. The company said it sees FY21 sales of $84 million to $84.5 million, versus analysts’ estimates of $90.9 million and also projects FY22 sales growth of 30% year over year. The company’s CEO Eric D. Hobbs will transition to president of Antibody Therapeutics Line.
• Curis, Inc. CRIS dropped 29.7% to $3.3950 after the company reported updated data with additional encouraging clinical activity in Phase 1/2 study of CA-4948 monotherapy in targeted patients with relapsed or refractory AML and MDS.
• CNS Pharmaceuticals, Inc. CNSP shares fell 27.6% to $0.7600 after the company reported a $11.5 million private placement priced at-the-market under Nasdaq rules.
• Sutro Biopharma, Inc. STRO dipped 24% to $11.07. Sutro Biopharma announced updated data from the Phase 1 study of STRO-002, an antibody-drug conjugate, for patients with advanced ovarian cancer, which showed that as of the Nov. 8 cut-off date, seven patients had achieved partial responses, five patients had unconfirmed partial responses and the overall response rate was 33% in all evaluable patients.
• Stran & Company, Inc. STRN fell 21.5% to $4.5905. Stran & Company announced a multi-year contract with a 'large national healthcare company.'
• Data Storage Corporation DTST shares fell 15.2% to $3.5005. Data Storage shares climbed more than 33% on Wednesday after the company announced a multi-million dollar contract with a professional sports team.
• Applied UV, Inc. AUVI dipped 15% to $2.53 after declining around 12% on Wednesday.
• Longeveron Inc. LGVN dropped 14.6% to $10.13. Longeveron recently announced initiation of the Phase 2a clinical trial of lomecel-B for the treatment of Alzheimer's Disease.
• NLS Pharmaceutics AG NLSP fell 14.5% to $1.2994. The company recently announced the USPTO granted the company U.S. Patent No. 11207271, entitled A Mazindol Ir/Sr Multilayer Tablet And Its Use For The Treatment Of Attention Deficit/Hyperactivity Disorder.
• Vivint Smart Home, Inc. VVNT fell 14.2% to $7.51. RBC Capital downgraded Vivint Smart Home from Outperform to Sector Perform and announced $11 price target.
• Heliogen, Inc. HLGN dropped 13.5% to $8.44.
• Marpai, Inc. MRAI fell 13% to $3.6974.
• Schnitzer Steel Industries, Inc. SCHN shares declined 12.5% to $46.82 after the company reported worse-than-expected Q1 EPS and sales results.
• Advanced Human Imaging Limited AHI fell 12.2% to $4.2220.
• Ebang International Holdings Inc. EBON shares fell 11.7% to $1.0050 after gaining around 10% on Wednesday.
• Hoth Therapeutics, Inc. HOTH shares fell 10.3% to $1.0401. Hoth Therapeutics recently announced proof-of-concept data generated using an Alzheimer's disease mouse model, supporting the therapeutic potential of HT-ALZ.
• REE Automotive Ltd. REE dropped 10.1% to $5.77. REE Automotive named David Goldberg as Chief Financial Officer.
• Humana Inc. HUM fell 9.9% to $410.33 after the company reaffirmed its FY21 EPS guidance below analyst estimates.
• MicroVision, Inc. MVIS shares fell 9.6% to $4.4680 after dropping more than 12% on Wednesday.
• Connect Biopharma Holdings Limited CNTB fell 9.1% to $4.5450. Connect Biopharma recently reported detailed dataset from global Phase 2b trial of CBP-201 in adult patients with moderate-to-severe atopic dermatitis.
• ATA Creativity Global AACG fell 8.1% to $2.1150 after dropping around 10% on Wednesday.
• ObsEva SA OBSV fell 6% to $1.9372. ObsEva announced positive topline results from the Phase 3 EDELWEISS 3 trial of linzagolix in women with moderate-to-severe endometriosis-associated pain.